BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17761539)

  • 21. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
    Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
    Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer.
    Melotti A; Mas C; Kuciak M; Lorente-Trigos A; Borges I; Ruiz i Altaba A
    EMBO Mol Med; 2014 Oct; 6(10):1263-78. PubMed ID: 25143352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of human cervical cancer proto-oncogene contributes to hepatitis B virus-induced malignant transformation of hepatocyte by down-regulating E-cadherin.
    Li J; Dai X; Zhang H; Zhang W; Sun S; Gao T; Kou Z; Yu H; Guo Y; Du L; Jiang S; Zhang J; Zhou Y
    Oncotarget; 2015 Oct; 6(30):29196-208. PubMed ID: 26470691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma.
    Fan X; Ma X; Cui L; Dang S; Qu J; Zhang J; Wang X; Mao Z
    Oncotarget; 2016 Dec; 7(49):80404-80414. PubMed ID: 27829235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. e2f1 Gene is a new member of Wnt/beta-catenin/Tcf-regulated genes.
    Abramova MV; Zatulovskiy EA; Svetlikova SB; Kukushkin AN; Pospelov VA
    Biochem Biophys Res Commun; 2010 Jan; 391(1):142-6. PubMed ID: 19900401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of NF-kappaB activity on beta-catenin/Tcf pathway in various cancer cells.
    Cho HH; Song JS; Yu JM; Yu SS; Choi SJ; Kim DH; Jung JS
    FEBS Lett; 2008 Mar; 582(5):616-22. PubMed ID: 18242184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of Wnt signaling by the nuclear pore complex.
    Shitashige M; Satow R; Honda K; Ono M; Hirohashi S; Yamada T
    Gastroenterology; 2008 Jun; 134(7):1961-71, 1971.e1-4. PubMed ID: 18439914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EB1 acts as an oncogene via activating beta-catenin/TCF pathway to promote cellular growth and inhibit apoptosis.
    Liu M; Yang S; Wang Y; Zhu H; Yan S; Zhang W; Quan L; Bai J; Xu N
    Mol Carcinog; 2009 Mar; 48(3):212-219. PubMed ID: 18680107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells.
    Lee HS; Lee DC; Park MH; Yang SJ; Lee JJ; Kim DM; Jang Y; Lee JH; Choi JY; Kang YK; Kim DI; Park KC; Kim SY; Yoo HS; Choi EJ; Yeom YI
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1059-67. PubMed ID: 16712787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
    Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
    Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Wnt10b on dermal papilla cells via the canonical Wnt/β-catenin signalling pathway in the Angora rabbit.
    Bai L; Gao S; Sun H; Zhao X; Yang L; Hu H; Sun J; Jiang W
    J Anim Physiol Anim Nutr (Berl); 2019 Sep; 103(5):1602-1609. PubMed ID: 31241227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation and migration mediated by Dkk-1/Wnt/beta-catenin cascade in a model of hepatocellular carcinoma cells.
    Qin X; Zhang H; Zhou X; Wang C; Zhang H; Zhang X; Ye L
    Transl Res; 2007 Nov; 150(5):281-94. PubMed ID: 17964517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
    Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
    Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The β-catenin/TCF complex as a novel target of resveratrol in the Wnt/β-catenin signaling pathway.
    Chen HJ; Hsu LS; Shia YT; Lin MW; Lin CM
    Biochem Pharmacol; 2012 Nov; 84(9):1143-53. PubMed ID: 22935447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WNT5A exhibits tumor-suppressive activity through antagonizing the Wnt/beta-catenin signaling, and is frequently methylated in colorectal cancer.
    Ying J; Li H; Yu J; Ng KM; Poon FF; Wong SC; Chan AT; Sung JJ; Tao Q
    Clin Cancer Res; 2008 Jan; 14(1):55-61. PubMed ID: 18172252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The WNT10B Network Is Associated with Survival and Metastases in Chemoresistant Triple-Negative Breast Cancer.
    El Ayachi I; Fatima I; Wend P; Alva-Ornelas JA; Runke S; Kuenzinger WL; Silva J; Silva W; Gray JK; Lehr S; Barch HC; Krutilina RI; White AC; Cardiff R; Yee LD; Yang L; O'Regan RM; Lowry WE; Seagroves TN; Seewaldt V; Krum SA; Miranda-Carboni GA
    Cancer Res; 2019 Mar; 79(5):982-993. PubMed ID: 30563890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fascin, a novel target of beta-catenin-TCF signaling, is expressed at the invasive front of human colon cancer.
    Vignjevic D; Schoumacher M; Gavert N; Janssen KP; Jih G; Laé M; Louvard D; Ben-Ze'ev A; Robine S
    Cancer Res; 2007 Jul; 67(14):6844-53. PubMed ID: 17638895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor suppressor Fbxw7 antagonizes WNT signaling by targeting β-catenin for degradation in pancreatic cancer.
    Jiang JX; Sun CY; Tian S; Yu C; Chen MY; Zhang H
    Tumour Biol; 2016 Oct; 37(10):13893-13902. PubMed ID: 27485116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.